All In Biotech

Drug Trial Radar · NCT03712124

A Study of CNSA-001 in Women With Diabetic Gastroparesis

A Phase 2, Randomized, Double-Blind, Placebo-Controlled Pilot Study of CNSA-001 in Women With Moderate to Severe Diabetic Gastroparesis

Last checked: Nov 20, 2026Latest source record: Jan 5, 2022 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedResults posted on the registry

Status

Completed

Enrollment

21

Actual

Start

Feb 27, 2019

Primary completion

Sep 8, 2019

Study completion Oct 8, 2019

Sponsor

Lead sponsor
PTC TherapeuticsIndustry
Sponsor type
Industry
First posted
Oct 19, 2018

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 2
Allocation
Randomized
Model
Parallel
Masking
Double (participant, investigator)
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
Female only, from 18 years, up to 75 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This study evaluates CNSA-001 (sepiapterin) in the treatment of women with moderate to severe diabetic gastroparesis. Participants will be randomized in a ratio of 1:1 to receive CNSA-001 20 (milligrams) mg/kilogram (kg)/day or placebo. All participants will receive the standard of care for diabetic gastroparesis.

Conditions

  • Gastroparesis

Interventions

  • CNSA-001Drug

    CNSA-001 Powder for Suspension

  • PlaceboDrug

    Placebo Suspension

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Change From Baseline (Day 1) in Maximal Tolerated Volume Consumed During the Nutrient Satiety Test at Day 14Time frame: Baseline (Day 1), Day 14
  2. Change From Baseline (Day 1) in Maximal Tolerated Volume Consumed During the Nutrient Satiety Test at Day 28Time frame: Baseline (Day 1), Day 28

Locations

6 sites in 1 country. Site status is shown where the registry gives one.

  • GW Research, Inc.

    Chula Vista, California

  • LMG Research

    Miami, Florida

  • Indiana University Hospital

    Indianapolis, Indiana

  • University of Louisville

    Louisville, Kentucky

  • Johns Hopkins University

    Baltimore, Maryland

  • Clinical Research Solutions, LLC

    Jackson, Tennessee

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.